| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |